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ICRC mouse, an inbred strain, developed at the Cancer
Research Institute, Bombay, exhibits mega-esophagus with
markedly hyperplastic mucosa. Diethylnitrosamine (DEN)
when given in drinking water at the dose of 4 mg/kg body
weight/day, induced esophageal papillomas consistently in
100% of the animals, in a short period of 12 weeks. Further,
tumors were produced, even at a very low cumulative dose
of 28 mg/kg body weight. Development of the esophageal
papillomas was dose dependent. DEN even induces esophageal
tumors transplacentally in the ICRC Fj progeny. Tobacco
acts predominantly as a promoter in this system. ICRC mouse
thus provides a much needed animal model to study
esophageal tumorigenesis, including the two-stage carcino-
genesis. An interesting feature of the study is that initiation
could be induced by exposure to low doses of DEN in the
intra-uterine life. Tumors develop in such F, animals only
if they are fed tobacco, a predominant promoter, post-natally.
Introduction
Esophageal cancer is a common cancer in many parts of the
world, including India. Its etiology and pathogenesis are still
poorly understood. Epidemiological studies suggest that environ-
mental factors, including consumption of alcohol and tobacco,
and nitrosamines, play an important role in the etiology of the
cancer (1). Amongst the host factors, achalasia, in which
constriction occurs at the gastro-esophageal junction, causing
retention of food in the esophagus and consequent chronic
irritation of the esophageal mucosa, is considered, by several
workers, to be a predisposing factor that can lead to esophageal
carcinoma in humans (2,3).
Cell proliferation plays a key role in induction of tumors (4).
Increased cellular proliferation, as seen in regenerating tissues,
could promote tumor development. Thus, it has been shown that,
as compared to the normal, the regenerating liver is more prone
to chemical carcinogenesis (5). Mucosal hyperplasia, observed
in achalasia, may be responsible for the higher incidence of cancer
in this condition.
Since 1957, an inbred strain of large-sized albino mice, named
ICRC/HiCri (ICRC), has been maintained by the Cancer
Research Institute, Bombay (6,7). The animals were originally
obtained from Haffkine Institute, Bombay, as a random-bred
colony. Inbreeding resulted in the development of a strain that
showed spontaneous mammary cancer and leukemia. In addition,
all adult animals of both sexes also show mega-esophagus in
which mucosa is markedly hyperplastic (7). The condition appears
•Abbreviations: DEN, diethylnitrosamine; H&E, hematoxylin and eosin.
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at — 3 weeks, but becomes evident at 3 months of age. In view
of the promotional effects of regeneration in chemical carcino-
genesis, it was felt that the ICRC mouse may readily develop
esophageal tumors on challenge with a suitable carcinogen.
Chemical carcinogenesis is considered to be at least a two-step
process, consisting of the stages of initiation and promotion.
Initiation could be induced even by exposure in the intra-uterine
period (8). F, and F2 progeny of mothers exposed to carcino-
gens develop tumors (9). Further, tumor incidence is increased
if such offsprings are also exposed to promoters post-natally. In
this study, we have shown that the ICRC mouse is a good model
to study the two-stage, as well as transplacental, esophageal
carcinogenesis. In this model, tobacco which is a known risk
factor for both oral and esophageal cancer (10), has been found
predominantly to be a promoter.
Materials and methods
Animals and treatment
Adult inbred ICRC mice were used in the study. Each animal was housed separately
in a cage and fed standard laboratory diet and water ad libitum. The starting weights
of the adult animals were 30-33 g. Diethylnitrosamine (DEN*) was administered
in different doses, depending on the experimental design, in drinking water, noting
daily consumption and thereby adjusting the dosage.
Four sets of experiments were conducted to test: (i) dose - response effects of
DEN; (ii) modifying influence of age on DEN-induced tumors; (lii) transplacemal
effects of DEN on me esophagus of the ICRC offspring; and (IV) modifying effects
of tobacco on DEN-induccd tumorigenesis. In all the post-natal carcinogenesis,
DEN was fed at the level of 4 mg/kg body weight/day. In the first set of
experiments, 2-month-old ICRC mice were fed DEN daily, and groups of animals
killed at 1, 2, 3, 4V4 and 6 months. It was observed that all animals developed
esophageal tumors beyond 3 months. Subsequently, to determine its minimum
effective cumulative dose, DEN was fed for only 1, 2, 4 and 8 weeks, giving
cumulative doses of 28, 56, 112 and 224 mg/kg body weight respectively. The
animals were killed at 3 and 6 months.
To study the modifying influence of age, a group of 15, 21-day-old weanling
mice (11 —14 g), were given DEN (4 mg/kg/day), in drinking water and killed
at 4'A months. The results were compared with animals treated similarly to those
in Experiment 1.
The third series of experiments had two sub-groups. In one of them, DEN
was administered to the pregnant mice for a continuous period of 7 days,
immediately on pregnancy, in its second or third week. Based on preliminary
studies 40 mg/day/kg body weight (cumulative dose 280 mg/kg body weight)
of DEN was fed to pregnant females in drinking water. The control group of
pregnant animals did not receive DEN. Offspring were reared in normal conditions
and no carcinogen was fed to them in the post-natal life. They were killed at
8 -9 months of age. A number of animals developed tumors. The best results
were obtained in the offspring of mothers fed DEN in the second week. In the
other sub-group, therefore, mothers received 20 mg DEN/kg/day in the second
week of pregnancy. When the offspring reached 10 weeks of age they were given
either normal diet or a diet containing 5% tobacco, and killed 6 months later.
This dose of DEN was chosen on the basis of preliminary studies which had
shown that, at this level, no tumors were produced in the F( animals.
In the fourth set of experiments, dry, powdered tobacco (Nicotiana tobaccum)
was mixed in the normal diet at a concentration of 5%. A locally popular brand
known as Pandharpuri chewing tobacco was used. The mixture containing tobacco
phis food was compressed in pelleted form and fed to the 2-month-old animals.
They were divided into three groups. Animals in Groups I and II were fed DEN
(4 mg/kg/day) for 2 months and 2 weeks respectively. Thereafter, for the next
3 months, half the animals from each group were fed normal diet, and the other
half tobacco-containing diet. The third group of animals were fed normal diet
for the first 2 months, followed by tobacco-containing diet for the next 3—Vh
months. All animals were killed at the end of the study.
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The x2 test was used for comparison of proportion of tumor-bearing animals;
however, when the cell frequencies were small, Fischer's exact test was applied.
For comparison of mean values, Student's West was used.
Histopathology
Animals were killed by cervical dislocation at intervals according to the
experimental design. A gross examination of all organs was carried out. The
esophagus was dissected completely open on a filter paper so that it remained
flat, and then fixed in Bouin's fixative. Longitudinal sections were taken from
the junctions of the upper and lower one third to the middle one third. In addition,
sections were taken from papillomas. Paraffin sections cut at 5 p were stained
with hematoxylin and eosin (H&E).
Results
The ICRC mouse and general appearance of esophagus
The pedigree chart of the ICRC mouse is shown in Figure 1.
On inbreeding, this animal showed peculiar characteristics. From
the fifth generation onwards the strain exhibited spontaneous
mammary tumors and leukemia. The tumors were seen in
- 2 5 - 3 0 % animals at the age of 10-12 months. In the 14th
generation, in addition, ~ 8% animals of both sexes also showed
mega-esophagus, which was seen in 100% animals after the 60th
generation. In this condition, a constriction occurs at the gastro-
esophageal junction due to failure of the muscles to relax after
each contraction. Due to this constriction, ingested food cannot
pass down into the stomach. The stagnation of food in the
esophagus results in dilation of upper esophagus. The condition
occurs at —3 weeks, and becomes evident at 2 - 3 months of
age. The condition was seen progressively in larger numbers of
animals and by the 60th generations, 100% animals showed
mega-esophagus. The incidence of spontaneous breast tumor and
leukemia has developed to 33 and 8% respectively. At present
the ICRC strain is in the 80th generation.
The gross appearance of the esophagus and stomach of the
animals at different ages is shown in Figure 2. Although some
dilation of the middle one third is observed even at 3 weeks, the
esophagus is grossly dilated only at 4 months and later. The extent
of dilation varied from animal to animal. Dilatation affects almost
the whole length, except in small portions of the proximal and
distal segments. Esophageal mucosa in a normal adult mouse
(Swiss) is lined by stratified squamous epithelium, three or four
cell layers thick, showing orderly keratinization (Figure 3a).
Mitotic figures are hardly ever seen. In the ICRC mouse of
comparable age, the mucosa is markedly hyperplastic, consisting
of six to eight cell layers, associated with hyperkeratosis and
parakeratosis (Figure 3b). Mitotic figures are frequently observed
in the basal cell layer. In some animals, foci of lymphocytic
infiltration are seen in the sub-mucosa. The muscular coat is
markedly hypertrophied. Ulceration, associated with chronic
inflammation of the sub-mucosa, is observed in some animals
at 8 months of age. We have so far examined > 100, 8-month-
old animals, but no papilloma has been seen in any of them.
General observations
At the start of the experiment the mean weight of the animals
was 31 g (Figure 4). Control animals progressively gained weight
throughout the study. The DEN-fed animals maintained body
weight for the first 3 months, but thereafter lost weight. However,
even at the end of the study, the weight loss was < 2 - 4 g.
Dose response of DEN
Esophagi of adult animals showed grossly no lesion up to
2 months of DEN feeding. However, by the third month, 100%
of the animals developed tumors (Figure 5). An average of 10
papillomas per esophagus was seen. With increasing duration and
higher cumulative dose of DEN, there was a progressive increase
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Fig. 1. Pedigree chart of ICRC mouse.
in the number of papillomas. The differences between 3 and
6 months were statistically significant. At 6 months, the number
was so large that it interfered with nutrition and the animals
frequently became moribund. Hence, the experiments were
terminated at this stage. None of the other organs, which included
stomach, liver, small intestines, lung, spleen and kidney, showed
any other abnormality or tumors. No comments could be made
on the effects of DEN on the incidence of the spontaneous tumors,
generally seen only in the animals > 10 months old, as even in
the maximal-duration experiments the animals were killed at
8 months. Further, at a cumulative dose as low as 28 mg/kg body
weight, papillomas were induced in 6 months (Table I). The
differences in DEN-dosage effect were specially observed at
3 months, with 28- and 56-mg cumulative-dose animals not
showing any tumors, and 112- and 224-mg cumulative-dose
animals, all showing two to six tumors. At the end of 6 months,
a progressive increase in the number of papillomas was seen as
the cumulative dose increased from 28 to 112 mg but thereafter
it plateaued. The mean number of papillomas in animals treated
with DEN up to 2 weeks was significantly lower (P < 0.001)
than those treated for 4 and 8 weeks.
Age-dependent modulations
The average number of papillomas per esophagus in 21-day-old
animals continuously fed DEN for4'/i months was 31.9 ± 2.09.
This was 1.8 times the number seen in similarly treated adult
animals (Figure 5). The differences were statistically significant
(P < 0.001).
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Fig. 2. Gross appearance of esophagus and stomach of ICRC (I) mice at different ages of 21 days (LHS), 4 months (middle) and 8 months (RHS), compared
with Swiss (S) mice of similar age.
a
Fig. 3. (a) Photomicrograph of a section of the esophagus of a normal adult Swiss mouse showing the mucosa which is two or three cells thick. No mitotic
figures are seen (H&E; X300). (b) A section of the esophagus of a normal adult ICRC mouse. The mucosa is hyperplastic and seven or eight cell layers
thick. The basal cell layer shows a few mitoses. There is also hypertrophy of the muscular coat (H&E; X300).
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Fig. 5. Histogram showing the number of esophageal papillomas in animals
fed DEN for different durations.
Transplacental effects of DEN
The offspring in the control group did not develop esophageaJ
tumors, whereas one or two papillomas were observed in off-
spring of DEN-fed mothers (Table H). The tumors were observed
in 30, 66.6 and 42% of the offspring whose mothers had received
DEN in the first, second or third week of pregnancy respectively.
The DEN-fed mothers, in all the three groups, showed one or
two papillomas per animal at 8 months of age, when they were
killed. The differences were found statistically significant when
F, progeny of the DEN-fed animals was compared as a group
with the control animals. However, the differences within the
various groups of DEN-fed progeny were not significant.
When DEN was fed at low dose (20 mg/kg/day), in the second
week of pregnancy, and progeny later fed normal diet, no tumors
were seen. However, if the offspring were given a diet containing
tobacco, tumors developed in 55% of animals. The differences
were statistically significant (P = 0.01; Table UI).
Effects of tobacco
The animals fed only DEN for 2 months showed three to six
papillomas per esophagus (Table IV). However, when DEN
treatment was followed by feeding of 5% tobacco diet, the
average number of papillomas increased 5-fold, ranging from
18 to 25 papillomas per esophagus. The difference in the number
of papillomas was highly significant (P < 0.001). With DEN
treatment of only 2 weeks, followed by normal diet, no tumors
were observed in the animals. However, after a 2-week DEN
treatment followed by a diet containing 5% tobacco, all the
animals (10/10) showed the presence of two to six tumors. The
group of animals fed only 5 % tobacco with no prior treatment
of DEN, did not show any papillomas during the same period.
Histopathology
Papillomas appeared on the entire surface of the esophagus. Their
density showed a gradient from proximal to distal end, with the
maximum number of papillomas in the lower-one-third region.
To begin with, they appeared to be small elevations of the
mucosa. But with time, they grew in size and showed a definite
pedicle and became pedunculated. The gross appearance of
papillomas in animals fed DEN for 4 lA months is shown in
Figure 6. At this stage a very large number of papillomas, many
of them with ulceration, were seen.
Although the timing of the appearance of papillomas and their
number differed in different experiments, the morphology of the
papillomas was similar. Morphologic changes are therefore
described together. The papillomas in the esophagus showed
squamous-cell differentiation. The histopathological changes
Table I. Dose —response
Duration of
DEN* treatment
(in weeks)
1
2
4
8
effect of DEN
Cumulative dose
(mg/kg body wt)
28
56
112
224
Animals killed
3 months
No. of
animals
8
10
12
8
after
No. of
papilloma-
bearing
animals
0
0
12
8
Mean no. of
papillomas/
tumor-
bearing
animal ± SE
2.9 ± 0.35
4.6 ± 0.39
6 months
No. of
animals
12
8
8
9
No. of
papilloma-
bearing
animal
6
8
8
9
Mcanb no. of
papillomas/
tumor-bearing
animal ± SE
2.2 ± 0.61
3.4 ± 0.42
11.4 ± 0.67
10.3 ± 0.43
*DEN was fed at 4 mg/kg/day.
bP < 0.001 (comparing the combined groups of 1-week and 2-week treatment, with the combined group of 4-week and 8-week treatment).
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involved, exclusively, areas of the surface epithelium, and were
characterized by hyperkeratosis, keratin pearl formation, basal
cell hyperplasia, increased thickness of the epithelium, and
papillomas which showed high cellular proliferation, evident by
the frequent presence of mitotic figures (Figure 7a and b). Foci
of lymphocytic infiltration were frequently observed in the
underlying submucosa. Ulceration, with associated chronic
inflammation, was particularly seen in large tumors (Figure 7a).
None of the tumors extended into the muscular coat, and no
distant metastasis was observed. However, in some papillomas,
cells exhibited loss of polarity and occasional groups of tumor
cells invaded the underlying tissue (Figure 7c). The changes were
consistent with carcinoma in situ or micro-invasive cancer. In
a rare animal frankly invasive tumors, without any lymph node
metastasis, were also seen after prolonged DEN feeding.
However, the dominant growth was a well-differentiated
squamous cell papilloma.
Tabte D. Tumor incidence of offspring of ICRC mice treated with DEN prenatally
Period of
prenatal DEN1
feeding
Total no. of
offspring
No. of papilloma-''
bearing animals
No. of papillomas/
tumor-bearing animal
(range)
First week
Second week
Third week
Control (no
DEN)
10
9
12
12
3 (30.0%)*
6 (66.6%)"
5 (41.7%)***
0
1.0
1-2
1-2
"DEN was fed at 40 mg/kg/day for 7 days in drinking water to the pregnant
mice. Offspring were killed at the age of 8 months.
bSignificantly different from control group at: *P = 0.16; **P = 0.003;
***p = 0.04.
Table OI. Effect of post-natal tobacco feeding on pre-nalally DEN-fed ICRC
offspring
Period of Post-natal
pre-natal DEN* treatment
feeding
Total no. of No. of Mean no. of
offspring papilloma- papillomas/
bearing tumor-bearing
animals animal ± SE
Second week
Second week
Normal diet
5% tobacco diet
0
6" 1.33 ± 0.33
"DEN fed at 20 mg/kg/day for 7 days in drinking water to the pregnant mice.
bP = 0.01 (compared with the control group).
Table IV. Effects of tobacco in DEN-treated ICRC mice
Treatment schedule No. of No. of tumor Mean no. of papillomas/
animals bearing animals tumor-bearing animal ± SE
DEN* + 5% tobacco
DEN* + normal diet
DENb + 5% tobacco
DEN* + normal diet
5% tobacco only
9
8
10
9
10
9
8
10
0
0
21.7
4.6
3.4
-
-
±
±
0.812c
0.375
0.231
"DEN (4 mg/kg/day) was given through drinking water for 2 months
continuously, followed by tobacco or normal diet.
bDEN (4 mg/kg/day) was given through drinking water for 2 weeks
continuously, followed by tobacco or normal diet.
CP < 0.001 (compared with corresponding control group).
Discussion
The ICRC mouse is perhaps the only strain that shows mega-
esophagus, a condition which is seen in some strains of dogs (11),
rats (12) and cats (13). It is a genetic disorder controlled by a
recessive gene and is due to a disturbance of the nerve plexus
in the lower end, resulting in impediment of passage of food,
and consequent dilatation (7,14). Its pathogenesis is similar to
megacolon.
DEN has been used as a carcinogen in different species of
animals. Depending on the dose and route of administration, it
affects different target organs (15). Even in the same species there
are strain variations. Liver, lungs and esophagus are the main
target tissues in rodents, and low dose favours induction of
esophageal tumors (16). However, in studies conducted so far,
tumor development takes at least 6 — 8 months, even on feeding
of high doses. Clapp and Craig (17), fed a cumulative dose of
924 mg/kg body weight of DEN, spread over 22 weeks, to
10-week-old RF mice. No tumors were observed at the end of
the treatment. However, in the following 2 months, 4% animals
developed esophageal cancer. Similarly, in the experiments of
Takayama and Oota (18), the minimum induction time for fore-
stomach papillomas in DEN-fed ICR and C3H mice, was found
to be 7 —8 months. One of the important features of this study
is that papillomas consistently develop in 100% ICRC mice, in
a very short period of 12 weeks. The esophagus is the only
affected organ. No tumors are seen in other organs. Further,
tumors are produced, even at a very low cumulative dose of
28 mg/kg body weight. Also, continuous feeding of the
carcinogen is not essential to induce esophageal tumors. Develop-
ment of papillomas is dose dependent and increases with
increasing duration of DEN feeding. In a recent study similar
conclusions have been drawn by Rubio (19). Like Reuber and
Lee (20), we also observed a higher incidence of tumors in
younger animals. Our data indicates, that the ICRC mouse is a
good model to study DEN-induced esophageal tumorigenesis.
Esophageal mucosa in the ICRC mouse is hyperplastic. This
may be the main reason why only esophageal tumors are
produced with such consistency in a relatively short exposure
to the carcinogen. Clinical, as well as experimental studies,
indicate that increased cell proliferation promotes tumorigenesis
(21—23). In man, there are several instances where high cell
turnover is associated with increased cancer risk in the gastro-
intestinal tract (21). High cell turnover has been observed in
colonic mucosa in multiple polyposis, sporadic adenomas and
ulcerative colitis (24-26). These conditions predispose to cancer.
The esophageal mucosa of 'normal' subjects from China's
Linxian county, which has a very high prevalence of esophageal
cancer, shows higher cell turnover, particularly in the upper cell
layers, when compared with the esophageal mucosa of a similar
person from Jiaoxian county, which is a low incidence area (27).
According to Lipkin (21), increased cell turnover could be used
as a biomarker of increased susceptibility to cancer in the gastro-
intestinal tract.
The significance of the development of papilloma in the
pathogenesis of esophageal carcinoma, needs to be investigated.
In rats given N-methyl-N-nitrosaniline, Napalkov and Pozhavisski
(28) demonstrated conclusively that carcinomas developed from
papillomas. Stinson et al. (29) also showed development of
papillary carcinomas from papillomas in rats treated with
yV-methyl-Af-benzylnitrosamine. In this study we generally
observed papillomas, occasionally some of them exhibited micro-
invasion, but frank infiltrative cancer was rarely seen. The
observation period in this study is rather short (— 6—8 months),
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Fig. 6. Gross appearance of ICRC mouse esophagus. (T) 4-month DEN-treated esophagus showing large papillomas, many with ulceration (arrows).
(C) Control esophagus of the same age animals, without any DEN treatment.
mainly because the animals become moribund after this period
as a consequence of the mega-esophagus resulting in food stasis
and aspiration pneumonia. This perhaps might be the reason why
we did not observe frank malignancy.
Epidemiological studies indicate that, in man, chewing of
tobacco increases the risk of cancer of the oral cavity and
esophagus (10,30). The precise role of tobacco whether it is a
carcinogen, promoter or both is not certain (31). Tobacco-specific
nitrosamines given in drinking water, have also been reported
to cause esophageal tumors in rats (32,33). On the other hand,
Bock el al. (34) observed that the alkaline extract of unburned
tobacco acts as a promoter. In the study there was a 5-fold
increase in tumor incidence when tobacco was fed to DEN-primed
animals. Our results are in concordance with Bock el al. (34),
showing that tobacco principally acts as a promoter. Since the
observation period in this study is rather short, no conclusions
could be drawn about the carcinogenic potential of tobacco.
Other interesting features of this study are that tumor initiation
could be induced by exposure to a low dose of DEN in utero,
and tumors developed only in animals post-natally fed tobacco
which, as mentioned above, is predominantly a promoter in our
system. Animals fed tobacco alone post-natally did not develop
tumors. Recently, Napalkov et al. (9) have observed a similar
phenomenon in progeny of the mice fed dimethylbenzanthracine
during pregnancy. The incidence of tumors in animals painted
with 12-0-tetradecanoylphorbol-13-acetate during post-natal life
was higher when compared to those exposed to only the
carcinogen in utero. In their study, however, both the groups
developed tumors and the promoter enhanced tumor growth. On
the other hand, in our model, tumors developed in the F, only
when they were fed a diet containing tobacco, at the low DEN
dose employed by us. The ICRC mouse appears, therefore, to
be an excellent model to study transplacental initiation and post-
natal promotion of esophageal carcinogenesis.
To our knowledge, there is no natural model to simulate human
tumors associated with tobacco chewing. Those who chew
tobacco, keep the bolus in the mouth for a very long period of
time (35). Tumors frequently occur at the site of contact of the
bolus with the oral mucosa. The ICRC mouse with a mega-
esophagus provides a good model. In these animals, because of
the slowing down of the passage of food, tobacco remains in
contact with the mucosa for a longer time. Also, no force feeding
is resorted to, and tobacco is taken freely by the animals. Attempts
have been made earlier to use the cheek pouch of the hamster,
but without much success (36). As the ICRC mouse shows a large
number of esophageal papillomas in a comparatively shorter
period of carcinogen exposure, it provides a suitable model to
study two-stage carcinogenesis. Our studies indicate that, the
ICRC mice could be used to study the effect of food ingredients,
e.g. capsaicin and other spices consumed daily in the food of
the Indian population, as promoters of esophageal tumorigenesis.
Further, the protective action of certain chemicals, e.g. retinoic
acid, could also be tested, by studying inhibition of papilloma
formation, on using the drug in conjunction with known carcino-
gens/promoters or both.
Nitrosamines, which are present widely in nature, have been
strongly incriminated as human carcinogens (37). The question
about what should be their 'permissible' limits for man is yet
to be solved. Animal data are often used to fix the 'permissible'
limits. Different species of animals are fed varying doses, for
life time, which in the case of rodents, is —2 years (38). The
level at which no tumors are produced, is used to fix human
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Fig. 7. (a) Low-power view of esophageal papilloma of ICRC mouse showing islands of cells infiltrating the underlying tissue (H&E; x60). (b) High-power
view of the papilloma showing a well-differentiated area in which the basal cell layer is intact and the cells are normally oriented (H&E; X240). (c) High-
power view of a portion of the papilloma showing groups of cells infiltrating into the deeper tissue. The tumor cells also show a large number of mitoses
(H&E; x240).
'permissible' limits. Lijinsky et al. (39) found that in adult Fischer
rats, a cumulative dose as low as 1.35 mg/animal could induce
tumors. In this study, tumors have been observed with a
cumulative dose of 28 mg/kg body weight or 0.87 mg/ICRC
mouse, considering that the average weight of the animals was
31 g. At this dose no tumors were seen at 3 months, but when
the DEN-primed animals were fed a tobacco diet, tumors
developed in 20% of the animals during the same period (data
not shown). These observations suggest that, in future, all
experiments aimed to determine 'permissible' levels, should
employ a two-stage protocol of initiation and promotion. Only
the dose at which no tumors are induced, even in the presence
of a promoter, should be considered as the 'no-effect' or 'safe'
level of a carcinogen.
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